Rapid Micro Biosystems Management
Management criteria checks 3/4
Rapid Micro Biosystems' CEO is Rob Spignesi, appointed in Oct 2014, has a tenure of 10.17 years. total yearly compensation is $1.80M, comprised of 34.3% salary and 65.7% bonuses, including company stock and options. directly owns 0.75% of the company’s shares, worth $289.47K. The average tenure of the management team and the board of directors is 3.9 years and 6.2 years respectively.
Key information
Rob Spignesi
Chief executive officer
US$1.8m
Total compensation
| CEO salary percentage | 34.3% |
| CEO tenure | 10.2yrs |
| CEO ownership | 0.7% |
| Management average tenure | 3.9yrs |
| Board average tenure | 6.2yrs |
Recent management updates
Recent updates
Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story
Nov 02
Is Rapid Micro Biosystems (NASDAQ:RPID) In A Good Position To Invest In Growth?
Oct 29A Piece Of The Puzzle Missing From Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 32% Share Price Climb
Aug 03We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate
Jun 30Rapid Micro to introduce RMBNucleus software for mold detection in pharma manufacturing
Oct 10Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth
May 09Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67
Mar 08We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate
Feb 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$48m |
| Jun 30 2024 | n/a | n/a | -US$50m |
| Mar 31 2024 | n/a | n/a | -US$52m |
| Dec 31 2023 | US$2m | US$617k | -US$52m |
| Sep 30 2023 | n/a | n/a | -US$58m |
| Jun 30 2023 | n/a | n/a | -US$61m |
| Mar 31 2023 | n/a | n/a | -US$60m |
| Dec 31 2022 | US$2m | US$593k | -US$61m |
| Sep 30 2022 | n/a | n/a | -US$59m |
| Jun 30 2022 | n/a | n/a | -US$68m |
| Mar 31 2022 | n/a | n/a | -US$69m |
| Dec 31 2021 | US$1m | US$507k | -US$78m |
| Sep 30 2021 | n/a | n/a | -US$77m |
| Jun 30 2021 | n/a | n/a | -US$63m |
| Mar 31 2021 | n/a | n/a | -US$60m |
| Dec 31 2020 | US$1m | US$445k | -US$45m |
Compensation vs Market: Rob's total compensation ($USD1.80M) is above average for companies of similar size in the US market ($USD654.40K).
Compensation vs Earnings: Rob's compensation has been consistent with company performance over the past year.
CEO
Rob Spignesi (55 yo)
10.2yrs
Tenure
US$1,797,254
Compensation
Mr. Robert G. Spignesi Jr., also known as Rob, has been Chief Executive Officer, President and Director of Rapid Micro Biosystems, Inc. since October 2014. Mr. Spignesi is employed at SGG Partners, LLC. He...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 10.2yrs | US$1.80m | 0.75% $ 289.5k | |
| Chief Financial Officer | 6.3yrs | US$923.84k | 0.54% $ 208.3k | |
| Chief Operating Officer | 3.9yrs | US$957.95k | 0.19% $ 74.9k | |
| Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| VP of Legal & Secretary | no data | no data | no data | |
| Senior Vice President of Sales & Marketing | 1.6yrs | no data | no data | |
| Senior Vice President of Product | 1.7yrs | no data | no data |
3.9yrs
Average Tenure
55yo
Average Age
Experienced Management: RPID's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 10.2yrs | US$1.80m | 0.75% $ 289.5k | |
| Independent Director | 8.8yrs | US$70.08k | 0% $ 0 | |
| Independent Director | 6.2yrs | US$65.25k | 0.19% $ 74.2k | |
| Independent Chairman of Board | 1.4yrs | US$71.01k | 0.12% $ 45.0k | |
| Independent Director | 6.7yrs | US$88.97k | 19.6% $ 7.6m | |
| Independent Director | 3.5yrs | US$70.25k | 0% $ 0 | |
| Independent Director | 3yrs | US$82.40k | 0.023% $ 9.0k |
6.2yrs
Average Tenure
55yo
Average Age
Experienced Board: RPID's board of directors are considered experienced (6.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:40 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Rapid Micro Biosystems, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tycho Peterson | J.P. Morgan |
| Tejas Savant | Morgan Stanley |
| Daniel Arias | Stifel, Equities Research |